Wed. 11 May 2022, 7:45am ET Benzinga Earnings, News


Pieris Pharmaceuticals (NASDAQ:PIRS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Pieris Pharmaceuticals beat estimated earnings by 36.36%, reporting an EPS of $-0.07 versus an estimate of $-0.11.

Revenue was down $4.64 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.17 which was followed by a 3.26% increase in the share price the next day.

Here's a look at Pieris Pharmaceuticals's past performance:


Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.30 -0.24 -0.26 -0.17
EPS Actual -0.13 -0.24 -0.25 -0.07
Revenue Estimate 2.45M 5.32M 2.07M 6.47M
Revenue Actual 8.44M 4.06M 3.29M 15.63M

To track all earnings releases for Pieris Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.